Genvor Incorporated (GNVR)

OTCMKTS · Delayed Price · Currency is USD
0.615
-0.035 (-5.38%)
At close: Feb 26, 2026
121.47%
Market Cap 21.18M
Revenue (ttm) n/a
Net Income (ttm) -1.16M
Shares Out 34.44M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,920
Average Volume 1,884
Open 0.650
Previous Close 0.650
Day's Range 0.076 - 0.750
52-Week Range 0.000 - 3.000
Beta 939,393.12
RSI 40.59
Earnings Date May 13, 2026

About Genvor

Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. Genvor Incorporated is based in Henderson, Nevada. [Read more]

Sector Materials
CEO Chad Pawlak
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol GNVR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.